vs

Side-by-side financial comparison of JFrog Ltd (FROG) and PROCEPT BioRobotics Corp (PRCT). Click either name above to swap in a different company.

JFrog Ltd is the larger business by last-quarter revenue ($145.3M vs $76.4M, roughly 1.9× PROCEPT BioRobotics Corp). JFrog Ltd runs the higher net margin — -10.5% vs -39.1%, a 28.6% gap on every dollar of revenue. On growth, JFrog Ltd posted the faster year-over-year revenue change (25.2% vs 11.9%). JFrog Ltd produced more free cash flow last quarter ($49.9M vs $-12.2M). Over the past eight quarters, PROCEPT BioRobotics Corp's revenue compounded faster (31.0% CAGR vs 20.4%).

JFrog Ltd is a global DevOps technology provider that delivers end-to-end software release, artifact management, and security solutions. It serves clients across tech, finance, retail, and manufacturing sectors, helping teams streamline development and delivery workflows for cloud, on-premises, and hybrid infrastructure.

PROCEPT BioRobotics Corp is a medical tech firm developing and commercializing robotic surgical solutions for urological care. Its flagship AquaBeam system provides image-guided minimally invasive therapy for benign prostatic hyperplasia, serving providers and patients across North America, Europe and global markets.

FROG vs PRCT — Head-to-Head

Bigger by revenue
FROG
FROG
1.9× larger
FROG
$145.3M
$76.4M
PRCT
Growing faster (revenue YoY)
FROG
FROG
+13.2% gap
FROG
25.2%
11.9%
PRCT
Higher net margin
FROG
FROG
28.6% more per $
FROG
-10.5%
-39.1%
PRCT
More free cash flow
FROG
FROG
$62.0M more FCF
FROG
$49.9M
$-12.2M
PRCT
Faster 2-yr revenue CAGR
PRCT
PRCT
Annualised
PRCT
31.0%
20.4%
FROG

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
FROG
FROG
PRCT
PRCT
Revenue
$145.3M
$76.4M
Net Profit
$-15.2M
$-29.8M
Gross Margin
77.9%
60.6%
Operating Margin
-14.7%
-40.6%
Net Margin
-10.5%
-39.1%
Revenue YoY
25.2%
11.9%
Net Profit YoY
34.4%
-58.3%
EPS (diluted)
$-0.13
$-0.54

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
FROG
FROG
PRCT
PRCT
Q4 25
$145.3M
$76.4M
Q3 25
$136.9M
$83.3M
Q2 25
$127.2M
$79.2M
Q1 25
$122.4M
$69.2M
Q4 24
$116.1M
$68.2M
Q3 24
$109.1M
$58.4M
Q2 24
$103.0M
$53.4M
Q1 24
$100.3M
$44.5M
Net Profit
FROG
FROG
PRCT
PRCT
Q4 25
$-15.2M
$-29.8M
Q3 25
$-16.4M
$-21.4M
Q2 25
$-21.7M
$-19.6M
Q1 25
$-18.5M
$-24.7M
Q4 24
$-23.2M
$-18.9M
Q3 24
$-22.9M
$-21.0M
Q2 24
$-14.3M
$-25.6M
Q1 24
$-8.8M
$-26.0M
Gross Margin
FROG
FROG
PRCT
PRCT
Q4 25
77.9%
60.6%
Q3 25
77.4%
64.8%
Q2 25
76.3%
65.4%
Q1 25
75.3%
63.9%
Q4 24
75.4%
64.0%
Q3 24
75.0%
63.2%
Q2 24
78.8%
59.0%
Q1 24
79.5%
56.2%
Operating Margin
FROG
FROG
PRCT
PRCT
Q4 25
-14.7%
-40.6%
Q3 25
-15.8%
-27.8%
Q2 25
-20.4%
-28.0%
Q1 25
-18.8%
-39.7%
Q4 24
-21.9%
-28.9%
Q3 24
-27.4%
-38.4%
Q2 24
-18.6%
-50.3%
Q1 24
-16.6%
-62.1%
Net Margin
FROG
FROG
PRCT
PRCT
Q4 25
-10.5%
-39.1%
Q3 25
-12.0%
-25.7%
Q2 25
-17.0%
-24.7%
Q1 25
-15.1%
-35.8%
Q4 24
-20.0%
-27.6%
Q3 24
-21.0%
-35.9%
Q2 24
-13.9%
-48.0%
Q1 24
-8.8%
-58.3%
EPS (diluted)
FROG
FROG
PRCT
PRCT
Q4 25
$-0.13
$-0.54
Q3 25
$-0.14
$-0.38
Q2 25
$-0.19
$-0.35
Q1 25
$-0.16
$-0.45
Q4 24
$-0.21
$-0.34
Q3 24
$-0.21
$-0.40
Q2 24
$-0.13
$-0.50
Q1 24
$-0.08
$-0.51

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
FROG
FROG
PRCT
PRCT
Cash + ST InvestmentsLiquidity on hand
$704.4M
$286.5M
Total DebtLower is stronger
$51.6M
Stockholders' EquityBook value
$887.4M
$365.9M
Total Assets
$1.3B
$508.1M
Debt / EquityLower = less leverage
0.14×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
FROG
FROG
PRCT
PRCT
Q4 25
$704.4M
$286.5M
Q3 25
$651.1M
$294.3M
Q2 25
$611.7M
$302.7M
Q1 25
$563.5M
$316.2M
Q4 24
$522.0M
$333.7M
Q3 24
$467.8M
$196.8M
Q2 24
$591.3M
$214.1M
Q1 24
$579.6M
$225.6M
Total Debt
FROG
FROG
PRCT
PRCT
Q4 25
$51.6M
Q3 25
$51.6M
Q2 25
$51.5M
Q1 25
$51.5M
Q4 24
$51.5M
Q3 24
$51.4M
Q2 24
$51.4M
Q1 24
$51.4M
Stockholders' Equity
FROG
FROG
PRCT
PRCT
Q4 25
$887.4M
$365.9M
Q3 25
$859.4M
$380.3M
Q2 25
$826.5M
$385.8M
Q1 25
$800.0M
$389.2M
Q4 24
$773.5M
$402.2M
Q3 24
$756.2M
$241.2M
Q2 24
$721.4M
$251.8M
Q1 24
$707.8M
$264.0M
Total Assets
FROG
FROG
PRCT
PRCT
Q4 25
$1.3B
$508.1M
Q3 25
$1.3B
$511.5M
Q2 25
$1.2B
$513.1M
Q1 25
$1.2B
$519.4M
Q4 24
$1.1B
$534.0M
Q3 24
$1.1B
$374.1M
Q2 24
$1.0B
$374.4M
Q1 24
$997.1M
$382.9M
Debt / Equity
FROG
FROG
PRCT
PRCT
Q4 25
0.14×
Q3 25
0.14×
Q2 25
0.13×
Q1 25
0.13×
Q4 24
0.13×
Q3 24
0.21×
Q2 24
0.20×
Q1 24
0.19×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
FROG
FROG
PRCT
PRCT
Operating Cash FlowLast quarter
$50.7M
$-10.3M
Free Cash FlowOCF − Capex
$49.9M
$-12.2M
FCF MarginFCF / Revenue
34.3%
-15.9%
Capex IntensityCapex / Revenue
0.6%
2.4%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$142.3M
$-58.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
FROG
FROG
PRCT
PRCT
Q4 25
$50.7M
$-10.3M
Q3 25
$30.2M
$-6.6M
Q2 25
$36.1M
$-15.0M
Q1 25
$28.8M
$-17.0M
Q4 24
$49.1M
$-32.4M
Q3 24
$27.6M
$-18.8M
Q2 24
$16.7M
$-15.7M
Q1 24
$17.5M
$-32.3M
Free Cash Flow
FROG
FROG
PRCT
PRCT
Q4 25
$49.9M
$-12.2M
Q3 25
$28.8M
$-9.5M
Q2 25
$35.5M
$-17.8M
Q1 25
$28.1M
$-18.8M
Q4 24
$48.5M
$-33.6M
Q3 24
$26.7M
$-19.0M
Q2 24
$16.0M
$-16.8M
Q1 24
$16.6M
$-34.2M
FCF Margin
FROG
FROG
PRCT
PRCT
Q4 25
34.3%
-15.9%
Q3 25
21.0%
-11.4%
Q2 25
27.9%
-22.5%
Q1 25
23.0%
-27.2%
Q4 24
41.8%
-49.2%
Q3 24
24.5%
-32.6%
Q2 24
15.5%
-31.4%
Q1 24
16.6%
-76.9%
Capex Intensity
FROG
FROG
PRCT
PRCT
Q4 25
0.6%
2.4%
Q3 25
1.0%
3.4%
Q2 25
0.5%
3.5%
Q1 25
0.5%
2.7%
Q4 24
0.5%
1.7%
Q3 24
0.9%
0.4%
Q2 24
0.7%
2.0%
Q1 24
0.8%
4.4%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

FROG
FROG

Segment breakdown not available.

PRCT
PRCT

Hand Pieces And Other Consumables$34.1M45%
System Sales And Rentals$27.5M36%
Other$9.8M13%
Service Revenue$5.0M7%

Related Comparisons